A clinical trial to study the effects of two techniques, myofascial release therapy and chest exercises on functions of the lungs and mobility of the chest wall in individuals with old respiratory condition.
Phase 2
- Conditions
- Health Condition 1: J449- Chronic obstructive pulmonary disease, unspecified
- Registration Number
- CTRI/2023/09/057416
- Lead Sponsor
- Dhruvi Gada
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
a) Participants diagnosed with Chronic Obstructive Pulmonary Disease (COPD)
b) All genders
c) Aged between 40 to 60 years
d) Stable condition for the past month (no exacerbation of symptoms)
Exclusion Criteria
a)Other Cardiorespiratory disorders (Grade 3 & 4 CCF)
b) Patients who have undergone recent cardiothoracic or abdominal surgery.
c) Patients who have a recent history of chest wall or abdominal trauma; substantial chest wall deformity
d) Dyspnea grade 4 on mMRC scale
e) Known contraindications to myofascial release therapy (malignancy, tumours, Rheumatoid arthritis, osteoporosis)
f) Pregnancy
g) Neuromuscular or musculoskeletal pathology
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method a) To evaluate the immediate effect of myofascial release therapy on lung functions & chest mobility in COPD using pulmonary function test (FEV1, FVC, VC, RV, ERV & TLC) & chest expansion measurement by tape method respectively. <br/ ><br>b)To evaluate the immediate effect of thoracic mobility exercise on lung functions and chest mobility in COPD using pulmonary function test (FEV1, FVC, VC, RV, ERV and TLC) and chest expansion measurement by tape method respectively. <br/ ><br>c) To compare the immediate effects of myofascial release therapy and thoracic mobility exercises on lung functions and chest mobility in COPD.Timepoint: The assessment will be taken before the start of the intervention & immediately after the intervention.
- Secondary Outcome Measures
Name Time Method ILTimepoint: NI